Antihypertensives, antibiotics, analgesics, and other drugs frequently used in pregnancy

Česká verzia

Authors: R. Brnka; doc. MUDr. Emőke Šteňová, PhD.
Authors place of work: I. Interná klinika Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice, Bratislava
Published in the journal: Prakt. Lék. 2011; 91(4): 193-199
Category: Various Specialization

Summary

The issue of the pharmacotherapy during pregnancy is very difficult, while every drug is potentially teratogenic. Even if medicaments contribute to inborn defects only in 1‰ of cases, it is highly advisable to avoid their use in all possible cases. Condition of the patient, cautiousness and the preponderant benefit against the possible risk are determinant factors in using medicaments during pregnancy.

Key words:
pregnancy, medicaments, antihypertensives, antibiotics, analgesics, antitussives, antidiarrheals, safety.

Zdroje

1. Gregor, V. Léky v organogenezi lidského plodu. Remedia 1997, 7, 5, s. 307–310.

2. Elis, J., Elisová, K. Léky v těhotenství. Praha: Avicenum, 1989.

3. Meadows, M. Pregnancy and the drug dilemma. FDA Consumer Magazine 2001.

4. Výbor pre odporúčania: Odporúčania Európskej hypertenziologickej spoločnosti a Európskej kardiologickej spoločnosti pre rok 2003 v manažmente artériovej hypertenzie pre rok 2003. Cardiol 2004, 13(1), s.33-72.

5. Lain, K.Y., Roberts, J.M. Contemporary concept of the patogenesis and management of preeclampsia. JAMA 288(15), p. 1847-1848.

6. Janků, K. Hypertenze v těhotenství. Brno: Institut pro další vzdělávání pracovníků v zdravotnictví 1998, 170 s.

7. Rey, E. Effect of methyldopa on umbilical and placental artery blood flow velocity waveforms. Obstet. Gynecol. 1992, 80, p. 783-787.

8. Lip, G.Y. Effect of atenolol on birthweight. Am. J. Cardiol. 1997, 79, p. 1436-1438.

9. Papatsonis, D.N., Lok, C.A., Bos, .J.M. et al. Calcium chanel blockers in management of preterm labor and hypertension in pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2001, 97, p. 122-140.

10. Khandelwal, M., Kumanova, M., Gaughan, J.P., Reece, E.A. Role of diltiazem in pregnant women with renal disease. J. Matern. Fetal. Med. 2002, 12, p. 408-412.

11. Karthikeyan, V.J., Ferner, R.E., Baghdadi, S. et al. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies. J. Hypertens. 2011, 29(2), p. 396-399.

12. Schultz, M., Wacker, J., Bastert, G. Effect of Urapidil in antihypertensive therapy of preeclampsia on newborns. Zentrabl. Gynekol. 2001, 123(9), p. 529–533.

13. Schaefer, Ch. Drugs during pregnancy and lactation. Handbook of prescription drugs and comparative risk assessment. London: Elsevier 2001, 368 p.

14. Duley, L., Gulmezoglu, A.M., Henderson-Smart, D.J. Anticonvulsants for women with pre-eclampsia. Cochrane Database Syst. Rev. 2003, 2, CD 000025.

15. Briggs, G.G., Freeman, R.K., Yaffe, S.J. Drugs in pregnancy and lactation. A reference guide to fetal and neonatal risk. Baltimore: Williams and Wilkins, 1994.

16. Christensen, B. Which antibiotics are appropriate for treating bacteriuria in pregnancy? J. Antimicrob. Chemother. 2000, 46, Suppl 1, p. 29-34.

17. Vaules, M.B., Ramin, K.D., Ramsey, P.S. Syphilis in pregnancy: a review. Prim. Care Update Ob/Gyns. 2000, 7, p. 26-30.

18. Krčméry, V. ml. a kol. Manuál antimikrobiálnej chemoterapie. Martin: Vydavateľstvo Osveta, 1993.

19. Berkovitch, M., Pastuszak, A., Gazarian, M. et al. Safety of the new quinolones in pregnancy. Obstet. Gynecol. 1994, 84(4), p. 535-538.

20. Czeizel, A.E., Rockenbauer, M., Olsen, J., Sorensen, H.T. A teratological study of aminoglycoside antibiotic treatment during pregnancy. Scand. J. Infect. Dis. 2000, 32 (3), p. 309-313.

21. Fargašová, J. a kol. Absencia včasnej i neskorej teratogenicity po podaní potencionálne teratogenických antibiotik u 214 novorodencov. Acta chemotherapeutica. 2004, 1, s. 23-30.

22. Glover, D.D., Amonkar, M., Rybeck, B.F., Tracy, T.S. Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am. J. Obstet. Gynecol. 2003, 188, p. 1039-1045.

23. Werler, M.M., Sheehan, J.E., Mitchell, A.A. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am. J. Epidemiol. 2002, 155, p. 26-31.

24. Black, R.A., Hill, D.A. Over-the-counter medications in pregnancy. Am. Fam. Physician, 2003, 67, p. 2517-2524.

25. The American College of Obstetricians and Gynecologists (ACOG) and the American College of Allergy, Asthma and Immunology (ACAAI). The use of newer asthma and allergy medications during pregnancy. Position Statement. Ann. Allergy. Asthma Immunol. 2000, 84, p. 475-480.

26. Berardi, R.R., McDermott, J.H., Newton, G.D. Handbook of non-prescription drugs: an interactive approach to self-care. Washington, DC: APhA Publications, 2004.

27. Schatz, M., Zeiger, R.S., Harden, K. et al. The safety of asthma and allergy medications during pregnancy. J. Allergy Clin. Immunol. 1997, 100, p. 301-306.

28. Heinonen, O.P., Slone, D., Shapiro, S. Birth defects and drugs in pregnancy. Littleton, Mass: Publishing Sciences Group; 1977.

29. Bolser, D.C. Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines. Chest 2006, 129, p. 238S-249S.

30. Mazzotta, P., Loebstein, R., Koren, G. Treating allergic rhinitis in pregnancy. Safety considerations. Drug Saf. 1999, 20(4), p. 361-375.

31. Saxen, I. Cleft palate and maternal diphenhydramine intake. Lancet 1974, 1, p. 407-408.

32. Zierler, S., Purohit, D. Prenatal antihistamine exposure and retrolental fibroplasias. Am. J. Epidemiol. 1986, 123, p. 192-196.

33. Briggs, G.G., Freeman, R.K., Yaffe, S.J. (eds.). Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins, 1998: 577-578, 627-8.

34. Gilbert-Barness, E., Barness, L.A., Wolff, J. et al. Aluminum toxicity. Arch. Pediatr. Adolesc. Med. 1998, 152, p. 511-512.

35. Katz, P.O., Castell, D.O. Gastroesophageal reflux disease during pregnancy. Gastroenterol. Clin. North. Am. 1998, 27, p. 153-167.

36. Czeizel, A.E., Toth, M., Rockenbauer, M. No teratogenic effect after clotrimazole therapy during pregnancy. Epidemiology 1999, 10, p. 437-440.

37. Mastroiacovo, P., Mazzone, T., Botto, L.D. et al. Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole. Am. J. Obstet. Gynecol. 1996; 175, p. 1645-1650.

38. Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR 1998, 47(RR-1), p. 1-118.